PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 108 filers reported holding PULMONX CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,160,008 | -60.5% | 112,295 | -49.9% | 0.00% | -100.0% |
| Q2 2023 | $2,936,325 | +72.8% | 223,976 | +47.3% | 0.00% | – |
| Q1 2023 | $1,699,696 | -41.0% | 152,030 | -55.5% | 0.00% | -100.0% |
| Q4 2022 | $2,879,047 | -74.4% | 341,524 | -49.4% | 0.00% | -66.7% |
| Q3 2022 | $11,241,000 | +73.1% | 674,734 | +53.0% | 0.00% | +200.0% |
| Q2 2022 | $6,493,000 | -47.8% | 441,104 | -12.0% | 0.00% | -66.7% |
| Q1 2022 | $12,430,000 | +267.5% | 501,022 | +375.1% | 0.00% | +200.0% |
| Q4 2021 | $3,382,000 | -38.8% | 105,456 | -31.4% | 0.00% | 0.0% |
| Q3 2021 | $5,530,000 | +33.2% | 153,704 | +63.4% | 0.00% | 0.0% |
| Q2 2021 | $4,151,000 | +106.5% | 94,080 | +223.1% | 0.00% | 0.0% |
| Q4 2020 | $2,010,000 | – | 29,118 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $886,000 | 3.13% |
| PURA VIDA INVESTMENTS, LLC | 1,327,065 | $19,534,000 | 1.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,465,901 | $51,018,000 | 1.05% |
| NEXT CENTURY GROWTH INVESTORS LLC | 453,098 | $6,669,000 | 0.87% |
| Novo Holdings A/S | 510,555 | $7,515,000 | 0.37% |
| Rock Springs Capital Management LP | 702,400 | $10,339,000 | 0.30% |
| RTW INVESTMENTS, LP | 691,255 | $10,175,000 | 0.26% |
| TimesSquare Capital Management, LLC | 1,214,204 | $17,873,000 | 0.25% |
| FORMULA GROWTH LTD | 54,951 | $809,000 | 0.22% |
| Champlain Investment Partners, LLC | 2,129,760 | $31,350,000 | 0.20% |